Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
for Metastatic Colorectal Cancer
14 locations incl. Chandler
Sponsor: Amgen
Sex: All·Age: 18+
Code: NCT06252649·Phase 3·Recruiting·Listed Feb 2024